Telling Fred
Director at OGEN; Director at CELL THERAPEUTICS INC
- Sold, on record
- $547k
- Dollars the filings state
- Form 4 sales
- 8
- Latest Dec 12, 2025
- Form 144 notices
- 2
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- OGENORAGENICS INCDirector
- CELL THERAPEUTICS INCDirector
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- CELL THERAPEUTICS INC477,606 shares
- OGEN7,307 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale CELL THERAPEUTICS INCPlan not statedSep 18, 2012 2012
Sold 18,874 shares at $2.86 ($54k)
Telling Fred, Director
Sold 11.1% of holdings ($488k position)151,879 shares leftFiling
- 2 Form 4 sale CELL THERAPEUTICS INCPlan not statedMay 30, 2013 +254 days
Sold 64,798 shares at $1.24 ($80k)
Telling Fred, Director
Sold 21.2% of holdings ($378k position)240,308 shares leftFiling
- 3 Form 4 sale CELL THERAPEUTICS INCPlan not statedMar 7, 2014 +281 days
Sold 72,095 shares at $3.75 ($271k)
Telling Fred, Director
Sold 15.2% of holdings ($1.8M position)401,170 shares leftFiling
- 4 Form 144 notice OGENNoticeNov 30, 2023 +3555 days
Filed to sell 3,500 shares ($13k)
Telling Fred, Director
No 10b5-1 planFirst sale on recordFiling
- 5 Form 4 sale OGENNo planNov 30, 2023 same day
Sold 3,500 shares at $3.57 ($12k)
Telling Fred, Director
No 10b5-1 planSold 8.4% of holdings ($149k position)38,345 shares leftFirst sale on recordFollows a Form 144Filing
- 6 Form 144 notice OGENNoticeDec 6, 2024 +372 days
Filed to sell 3,597 shares ($1k)
Telling Fred, Director
No 10b5-1 planFirst sale on recordFiling
- 7 Form 4 sale OGENNo planDec 6, 2024 same day
Sold 3,597 shares at $0.36 ($1k)
Telling Fred, Director
No 10b5-1 planSold 9.4% of holdings ($14k position)34,748 shares leftFirst sale on recordFollows a Form 144Filing
- 8 Form 4 sale OGENNo planDec 12, 2025 +371 days
Sold 210 shares at $0.94 ($197)
Telling Fred, Director
No 10b5-1 planSold 0.6% of holdings ($33k position)34,538 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (10)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Dec 15, 2025 | OGEN | Director | Form 4 sale | 210 | $197 | 0.6% | No plan | SEC |
| Dec 6, 2024 | Dec 9, 2024 | OGEN | Director | Form 4 sale | 3,597 | $1k | 9.4% | No plan | SEC |
| Dec 6, 2024 | Dec 6, 2024 | OGEN | Director | Form 144 notice | 3,597 | $1k | Notice | SEC | |
| Nov 30, 2023 | Dec 1, 2023 | OGEN | Director | Form 4 sale | 3,500 | $12k | 8.4% | No plan | SEC |
| Nov 30, 2023 | Nov 30, 2023 | OGEN | Director | Form 144 notice | 3,500 | $13k | Notice | SEC | |
| Mar 7, 2014 | Mar 7, 2014 | CELL THERAPEUTICS INC | Director | Form 4 sale | 72,095 | $271k | 15.2% | Plan not stated | SEC |
| May 30, 2013 | May 31, 2013 | CELL THERAPEUTICS INC | Director | Form 4 sale | 64,798 | $80k | 21.2% | Plan not stated | SEC |
| Sep 18, 2012 | Sep 20, 2012 | CELL THERAPEUTICS INC | Director | Form 4 sale | 18,874 | $54k | 11.1% | Plan not stated | SEC |
| Nov 5, 2010 | Nov 8, 2010 | CELL THERAPEUTICS INC | Director | Form 4 sale | 216,016 | $84k | 12.0% | Plan not stated | SEC |
| Jun 29, 2010 | Jul 1, 2010 | CELL THERAPEUTICS INC | Director | Form 4 sale | 105,823 | $44k | 11.8% | Plan not stated | SEC |